

27 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/27/3263952/0/en/LB-Pharmaceuticals-Presents-New-Analysis-from-the-Phase-2-NOVA-1-Trial-Highlighting-LB-102-s-Potential-Impact-on-Cognitive-Performance-at-the-2026-Annual-Congress-of-the-Schizophre.html

25 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/25/3262125/0/en/LB-Pharmaceuticals-Initiates-Pivotal-Phase-3-Trial-NOVA-2-for-LB-102-in-Patients-with-Schizophrenia.html